Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

European and US guidelines emphasise the importance of identifying and treating all adults with CVD or at high risk for developing CVD. Although tools are available that can aid in the identification and treatment of individuals at risk, substantial opportunities to reduce morbidity and mortality are being missed. If the rising toll of CVD is to be reduced, preventive cardiology for individuals at risk for CHD must become a medical priority. Identification of at-risk individuals and institution of aggressive risk factor modification must become standard practice, in compliance with international treatment guidelines. The complexity of the population screening, the surveillance of those at risk, the requirement to intervene to specific targets, and the need to audit to satisfactory standards will be a considerable challenge to all health providers.

Original publication




Journal article



Publication Date





1217 - 1223